Roger N. Rosenberg

20.3k total citations · 2 hit papers
192 papers, 5.9k citations indexed

About

Roger N. Rosenberg is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Roger N. Rosenberg has authored 192 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 59 papers in Physiology and 40 papers in Neurology. Recurrent topics in Roger N. Rosenberg's work include Alzheimer's disease research and treatments (50 papers), Dementia and Cognitive Impairment Research (23 papers) and Genetic Neurodegenerative Diseases (18 papers). Roger N. Rosenberg is often cited by papers focused on Alzheimer's disease research and treatments (50 papers), Dementia and Cognitive Impairment Research (23 papers) and Genetic Neurodegenerative Diseases (18 papers). Roger N. Rosenberg collaborates with scholars based in United States, Canada and Germany. Roger N. Rosenberg's co-authors include Sami I. Said, Fred Baskin, Myron Weiner, Doris Lambracht‐Washington, Lawrence S. Honig, C. Munro Cullum, Linda S. Hynan, Stephen C. Waring, Samuel H. Wilson and Marshall W. Nirenberg and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Roger N. Rosenberg

183 papers receiving 5.6k citations

Hit Papers

Markers for Gene Expression in Cultured Cells from the Ne... 1972 2026 1990 2008 1972 1981 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Markers for Gene Expression in Cultured Cells from the Nervous System
    1972 359 citations Roger N. Rosenberg et al. profile →
  2. Experimental and Clinical Neurotoxicology
    1981 300 citations Roger N. Rosenberg profile →

Peers

Roger N. Rosenberg
Sylvie Chalon France
Chaim G. Pick Israel
Jan Krzysztof Blusztajn United States
Christian Humpel Austria
Wei‐Yi Ong Singapore
Christine Hulette United States
Jonathan D. Geiger United States
Jean‐Jacques Martin Belgium
Jacques Hugon France
Edward G. Stopa United States
Sylvie Chalon France
Roger N. Rosenberg
Citations per year, relative to Roger N. Rosenberg Roger N. Rosenberg (= 1×) peers Sylvie Chalon

Countries citing papers authored by Roger N. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Roger N. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger N. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger N. Rosenberg more than expected).

Fields of papers citing papers by Roger N. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger N. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger N. Rosenberg. The network helps show where Roger N. Rosenberg may publish in the future.

Co-authorship network of co-authors of Roger N. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Roger N. Rosenberg. A scholar is included among the top collaborators of Roger N. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger N. Rosenberg. Roger N. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenberg, Roger N.. (2021). The universal brain code a genetic mechanism for memory. Journal of the Neurological Sciences. 429. 118073–118073. 2 indexed citations
2.
Rosenberg, Roger N., Min Fu, & Doris Lambracht‐Washington. (2018). Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology. Alzheimer s Research & Therapy. 10(1). 115–115. 34 indexed citations
3.
Tosto, Giuseppe, Thomas D. Bird, David A. Bennett, et al.. (2016). The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurology. 73(10). 1231–1231. 41 indexed citations
4.
Qu, Bao‐Xi, Yunhua Gong, Carol Moore, et al.. (2014). Beta-amyloid auto-antibodies are reduced in Alzheimer's disease. Journal of Neuroimmunology. 274(1-2). 168–173. 42 indexed citations
5.
Lambracht‐Washington, Doris & Roger N. Rosenberg. (2014). Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4 + CD25 + Foxp3 + T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy. Journal of Neuroimmunology. 278. 90–99. 17 indexed citations
6.
Lambracht‐Washington, Doris & Roger N. Rosenberg. (2014). A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients. Neurobiology of Aging. 36(3). 1274–1281. 10 indexed citations
7.
Lambracht‐Washington, Doris & Roger N. Rosenberg. (2013). Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease. ImmunoTargets and Therapy. 2013(2). 105–105. 29 indexed citations
8.
Lambracht‐Washington, Doris, et al.. (2010). Analysis of three plasmid systems for use in DNA Aβ42 immunization as therapy for Alzheimer's disease. Vaccine. 28(32). 5280–5287. 27 indexed citations
9.
Qu, Bao‐Xi, Qun Xiang, Liping Li, et al.. (2007). Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice. Journal of the Neurological Sciences. 260(1-2). 204–213. 45 indexed citations
10.
Rosenberg, Roger N.. (2005). Translational Research on the Way to Effective Therapy for Alzheimer Disease. Archives of General Psychiatry. 62(11). 1186–1186. 37 indexed citations
11.
Tang, Kun, Linda S. Hynan, Fred Baskin, & Roger N. Rosenberg. (2005). Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease. Journal of the Neurological Sciences. 240(1-2). 53–58. 113 indexed citations
12.
Lacritz, Laura H., et al.. (2004). Category Fluency in Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders. 18(3). 120–122. 107 indexed citations
13.
Weiner, Myron, Kyle Womack, Doris Svetlik, et al.. (2003). Comparison of Alzheimer’s Disease in Native Americans and Whites. International Psychogeriatrics. 15(4). 367–375. 17 indexed citations
14.
Rosenberg, Roger N.. (2003). The molecular and genetic basis of neurologic and psychiatric disease. Lippincott Williams & Wilkins eBooks. 65 indexed citations
15.
Lacritz, Laura H., et al.. (2001). Effects of Practice on Category Fluency in Alzheimers Disease*. The Clinical Neuropsychologist. 15(1). 125–128. 60 indexed citations
16.
Honig, Lawrence S. & Roger N. Rosenberg. (2000). Apoptosis and neurologic disease. The American Journal of Medicine. 108(4). 317–330. 200 indexed citations
17.
Rosenberg, Roger N. & Erica Anderson. (1999). Editorial Governance of the Journal of the American Medical Association. JAMA. 281(23). 2239–2239. 8 indexed citations
18.
Terry, John B. & Roger N. Rosenberg. (1995). Frontal lobe ataxia. Surgical Neurology. 44(6). 583–588. 14 indexed citations
19.
Rosenberg, Roger N. & Susan T. Iannaccone. (1995). The Prevention of Neurogenetic Disease. Archives of Neurology. 52(4). 356–362. 4 indexed citations
20.
Farrer, Lindsay A., Patrick MacLeod, João Radvany, et al.. (1994). Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus. Human Genetics. 93(3). 335–338. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie Chalon Breakdown of academic impact, for papers by Chaim G. Pick Breakdown of academic impact, for papers by Jan Krzysztof Blusztajn Breakdown of academic impact, for papers by Christian Humpel Breakdown of academic impact, for papers by Wei‐Yi Ong Breakdown of academic impact, for papers by Christine Hulette Breakdown of academic impact, for papers by Jonathan D. Geiger Breakdown of academic impact, for papers by Jean‐Jacques Martin Breakdown of academic impact, for papers by Jacques Hugon Breakdown of academic impact, for papers by Edward G. Stopa
Rankless by CCL
2026